[1] |
YAO Xinyi, HE Tong, YANG Xinya, XU Mingcheng, ZHANG Junling.
Research progress on interleukin-17C in autoimmune skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2025, 41(1): 69-72.
|
[2] |
Dilinuer TAXIMAIMAITI, Palida ABULIZI.
Efficacy and safety of abrocitinib and dupilumab in the treatment of moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 533-537.
|
[3] |
GUO Shuting, LI Ruijie, YANG Meili, JIN Yaqiao, ZHAO Yiyu, ZHANG Lu, HAN Hui, HAO Yong.
Effect of dupilumab on Staphylococcus aureus colonization in adults with moderate to severe atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 545-549.
|
[4] |
LIU Siqi, DENG Danqi.
Progress of research on high salt diet in systemic lupus erythematosus
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(8): 602-606.
|
[5] |
XU Yuanyuan, GUO Linghong, WU Shuwei, ZHANG Ting, ZHANG Lu, JIANG Xian.
Causal associations between three atopic diseases and alopecia areata: a two-sample Mendelian randomization study
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 239-244.
|
[6] |
CHEN Xueqin, SONG Zhiqiang.
Update of skin tissue-resident memory T cells and inflammatory skin diseases recurrence
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 292-296.
|
[7] |
HAN Jinghong, LIU Hong.
Two children with refractory atopic dermatitis successfully treated with Janus kinase inhibitors
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 190-192.
|
[8] |
LI Yanbo, ZHU Junrong, WANG Shangshang.
Bullous pemphigoid secondary to atopic dermatitis: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(11): 809-811.
|
[9] |
HUANG Gerile, ZHANG Wenjing, YANG Hongxin, GUO Hao.
Efficacy and safety of Janus kinase inhibitors for moderate-to-severe atopic dermatitis: a network meta-analysis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(10): 690-698.
|
[10] |
ZHOU Xiaonan, CAO Chunyan, SHI Yaping, QI Maoxuan, ZHANG Qianying, ZONG Yan.
Latent profile analysis of family management characteristics in children with atopic dermatitis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 39-44.
|
[11] |
WEI Mingjing, CHEN Wenqi.
Update of TRPV3 in the occurrence and treatment of skin diseases
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 66-70.
|
[12] |
ZHOU Lingxuan, ZHAO Yang, YUAN Xiaohui, XU Zhe, LIU Lingling, WANG Yang, ZHAO Jiahui.
Neuroimmune mechanisms of IL-33 involved in type 2 inflammatory pruritus
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 688-692.
|
[13] |
YANG Xiaoli, DENG Danqi.
Research progress of atopic dermatitis and metabolic syndrome
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(8): 614-618.
|
[14] |
GUO Shufen, WU Jiahui, LIU Boyan, CHEN Wenwen, GENG Biao, LIU Zhichao.
Effects of hydrogen on proliferation of HaCaT keratinocytes and expression of inflammatory factors
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 501-504.
|
[15] |
YANG Zijing, PAN Meng, ZHAO Xiaoqing.
Dupilumab-induced immune drifting from atopic dermatitis to polymyalgia rheumatica: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(7): 508-511.
|